A study of male veterans with diabetes has found that incidence of diabetic foot ulcer (DFU) is the most powerful independent risk factor for lower‐extremity amputation, representing roughly a tenfold...
Afon Technology’s Glucowear™ device has achieved approximately 75 per cent overall accuracy in distinguishing between normal and elevated blood glucose levels during its first, real-world trial. The i...
A free, educational webinar for healthcare professionals will take place next month to officially launch The CKM Collaborative (formerly CVRM UK). Taking place at 7pm on Thursday April 30, 2026, the w...
Population-wide autoimmunity screening for type 1 diabetes across all age groups is feasible using minimally invasive capillary sampling and advanced immunoassay technology, latest research has claime...
The emotional burden of amputation, the impact of Martha’s Law and palliative care are just some of the topics of the next EDFN National Conference. Register now to hear from expert speakers at the fr...
An expert paper discussing pump, continuous glucose monitoring and whole system features to guide the personalised selection of hybrid closed-loop systems currently available in Italy has been publish...
The LIM and SH3 protein 1 (LASP1) regulates the synthesis and activation of A Disintegrin and Metalloproteinase 17 (ADAM17) in mesangial cells and is required for the profibrotic response to high gluc...
The Secretary of State for Health and Social Care is “determined to make real improvements in diagnosing type 1 diabetes” to ensure no child is “let down by the NHS”, following the death of two-year-o...
The world’s first fully closed-loop feature will become available within the existing CamAPS® FX app. In a pioneering move for type 1 diabetes care, CamDiab’s new CamAPS Liberty feature will support ...